TickerStat.com

Organogenesis Holdings Inc. (ORGO)

Price—Loading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

10 annual periodsNewest to oldest
2025202420232022202120202019201820172016
Revenue$564.2M$482.0M$433.1M$450.9M$467.4M$338.3M$261.0M$193.4M$198.5M$138.7M
Gross profit—$366.3M$326.7M$345.9M$353.2M$251.0M$185.0M$124.6M$137.3M$90.5M
Research & development$44.5M$50.3M$44.4M$39.8M$30.7M$20.1M$14.8M$10.7M$9.1M$6.3M
Operating expenses$519.5M$483.3M$420.6M$323.6M$280.9M$224.3M$214.9M$176.2M$142.8M$99.3M
Operating income$44.7M−$1.3M$12.5M$22.3M$72.2M$26.7M−$29.9M−$51.6M−$5.5M−$8.8M
EBITDAderived$60.0M$12.3M$23.0M$28.1M$82.9M$34.9M−$20.0M−$44.6M$134,000−$1.5M
Net income$37.0M$861,000$4.9M$15.5M$94.2M$17.2M−$38.7M−$64.8M−$8.4M−$17.0M
Basic EPSper diluted share$0.16-$0.01$0.04$0.12$0.73$0.16-$0.42-$0.94-$0.14-$0.27
Diluted EPSper diluted share$0.15-$0.01$0.04$0.12$0.70$0.15-$0.42-$0.94-$0.14-$0.27
Review source filings at SEC.gov ↗

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys7$1.86M disclosed value
Sells (SEC code S)14$4.19M disclosed value
21 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Mar 9, 2026Form 4Leibowitz Arthur SDirectorBuyClass A Common Stock5.0K$2.68$13.4K291.0K
Mar 9, 2026Form 4Driscoll Michael JosephDirectorBuyClass A Common Stock10.0K$2.67$26.7K225.7K
Dec 16, 2025Form 4NUSSDORF GLENN HDirectorSellClass A Common Stock200.0K$5.14$1.03M2.57M
Nov 26, 2025Form 4NUSSDORF GLENN HDirector,TenPercentOwnerSellClass A Common Stock188.0K$5.29$994.3K2.77M
Nov 25, 2025Form 4NUSSDORF GLENN HDirector,TenPercentOwnerSellClass A Common Stock12.0K$5.30$63.8K2.95M
Review ownership filings at SEC.gov ↗